MedTrace Logo

Use of Export in Primary Percutaneous Coronary Intervention

NCT05510661 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-04-09

No results posted yet for this study

Summary

Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.

Conditions

  • ST-segment Elevation Myocardial Infarction (STEMI)
  • Total Occlusion of Coronary Artery
  • Primary Percutaneous Coronary Intervention

Interventions

DEVICE

Export Catheter

Manual thrombus aspiration with the use of export catheter during primary PCI

DEVICE

Balloon catheter

Predilatation with balloon catheter

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • National Institute of Cardiovascular Diseases, Pakistan

    lead OTHER

Principal Investigators

  • Dr Fiaza Farooq, FCPS · National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-09-24
Completion
2026-05-31
FDA Device
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05510661 on ClinicalTrials.gov